G7 Therapeutics AG, sold and renamed 2017
G7 Therapeutics (renamed in January 2017 to Heptares Therapeutics Zurich AG, Schlieren) utilises proprietary approaches to stabilise G protein-coupled receptors (GPCRs) and enables novel structure-bas...load more
G7 Therapeutics AG, sold and renamed 2017's Basic Information
Industry
Pharmaceutical Manufacturing
Headquarters
Switzerland
Website
Founded Year
2013
Headcount
2 - 10 ( View All )
G7 Therapeutics AG, sold and renamed 2017's Competitors
Employee Insights
G7 Therapeutics AG, sold and renamed 2017's Top Employees
Dirk Tremmel
Business development and administration, Co-founder
Phone Email
Carlo Bertozzi
CEO, Business Strategy and Operations
Phone Email
Frequently Asked Questions Regarding G7 Therapeutics AG, sold and renamed 2017
Where is G7 Therapeutics AG, sold and renamed 2017's headquarter located?
G7 Therapeutics AG, sold and renamed 2017's headquarter are located at Switzerland.
How many employees does G7 Therapeutics AG, sold and renamed 2017 have?
G7 Therapeutics AG, sold and renamed 2017 has 2 - 10 employees.
What is G7 Therapeutics AG, sold and renamed 2017's official website?
G7 Therapeutics AG, sold and renamed 2017's official website is http://g7therapeutics.com
What industry does G7 Therapeutics AG, sold and renamed 2017 belong to?
G7 Therapeutics AG, sold and renamed 2017 is in the industry ofPharmaceutical Manufacturing
What does G7 Therapeutics AG, sold and renamed 2017 do?
G7 Therapeutics (renamed in January 2017 to Heptares Therapeutics Zurich AG, Schlieren) utilises proprietary approaches to stabilise G protein-coupled receptors (GPCRs) and enables novel structure-bas...
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts